ABIN116870
antibody from antibodies-online
Targeting: TNFRSF1A
CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN116870 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) antibody
- Antibody type
- Polyclonal
- Antigen
- The whole rabbit serum used to produce this IgG fraction antibody was prepared byrepeated immunizations with recombinant human sTNFRp55 expressed in Chinese HamsterCells.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 1 mg
- Concentration
- 1.0 mg/ml (by UV absorbance at 280 nm)
- Storage
- Store the antibody (undiluted) at 2-8°C for one month or (in aliquots) at -20°C for longer. Dilute only prior to immediate use. Avoid cycles of freezing and thawing. Shelf life: One year from despatch.
Submitted references Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
Aderka D, Sorkine P, Abu-Abid S, Lev D, Setton A, Cope AP, Wallach D, Klausner J
The Journal of clinical investigation 1998 Feb 1;101(3):650-9
The Journal of clinical investigation 1998 Feb 1;101(3):650-9
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D
The Journal of experimental medicine 1992 Feb 1;175(2):323-9
The Journal of experimental medicine 1992 Feb 1;175(2):323-9
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.
Aderka D, Englemann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G
Cancer research 1991 Oct 15;51(20):5602-7
Cancer research 1991 Oct 15;51(20):5602-7
Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
Engelmann H, Novick D, Wallach D
The Journal of biological chemistry 1990 Jan 25;265(3):1531-6
The Journal of biological chemistry 1990 Jan 25;265(3):1531-6
No comments: Submit comment
No validations: Submit validation data